|1.||Hou, S-P: 1 article (07/2013)|
|2.||Huang, L-H: 1 article (07/2013)|
|3.||Cheng, L-N: 1 article (07/2013)|
|4.||Chen, O-J: 1 article (07/2013)|
|5.||Teng, Y-C: 1 article (07/2013)|
|6.||Wang, Le-Xin: 1 article (02/2013)|
|7.||Sun, Ying-Chun: 1 article (02/2013)|
|8.||Zhang, Gai-Ying: 1 article (02/2013)|
|9.||Qiu, Ren-Feng: 1 article (02/2013)|
|10.||Hua, Cai: 1 article (04/2009)|
06/01/2004 - "Animals were administered by GNK and nilestriol respectively, through gastric perfusion, for 3 months to observe the therapeutic effect of drug treatment on osteoporosis and the regulatory effect on endocrine and immune function. "
10/28/2001 - "The treatment of nilestriol and levenorgestrel may decrease the bone turnover and correct the imbalance to cure the osteoporosis."
03/01/1993 - "[Nilestriol prevents osteoporosis in ovariectomized rats]."
06/01/2000 - "To evaluate the anti-osteoporosis effect of clodronate in ovariectomized rats, 44 female Wistar rats, aged 8 months, were divided randomly into 4 groups: the SHAM group (subjected to sham operation); the OVX group (subjected to bilateral ovariectomy); the E3 group (subjected to bilateral ovariectomy and treated after surgery with nilestriol 1 mg/kg BW by gavage once a week for 12 weeks), and the clodronate group (subjected to bilateral ovariectomy and treated after surgery with clodronate 5 mg/kg BW by subcutaneous injection twice a week for 12 weeks). "
|2.||Carotid Artery Injuries
02/01/2013 - "Forty-eight female New Zealand rabbits were randomly divided into four groups: control (balloon-induced carotid artery injury only); ovariectomy control (ovariectomy and carotid artery injury), oestrogen (ovariectomy, carotid artery injury and nilestriol, 5mg/kg daily for 28 days), and isoflavone (ovariectomy, carotid artery injury and isoflavone 120 mg/kg daily for 28 days). "
|5.||Hypertension (High Blood Pressure)
|2.||Clodronic Acid (Clodronate)
|3.||salicylhydroxamic acid (SHAM)